Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 42, 2012, Pages

  Blau, Lior ^a   Knirsh, Revital ^a   Ben Dror, Iris ^a   Oren, Sivan ^a   Kuphal, Silke ^b   Hau, Peter ^b   Proescholdt, Martin ^b   Bosserhoff, Anja Katrin ^b   Vardimon, Lily ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INITIATION FACTOR 4E BINDING PROTEIN 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C FOS; PROTEIN C JUN; RNA 18S; TUBULIN;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; ASTROCYTOMA; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; GLIOBLASTOMA; HALF LIFE TIME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNAL RIBOSOME ENTRY SITE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTO ONCOGENE; RAT; TRANSLATION REGULATION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMES;

EID: 84867660631     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1203659109     Document Type: Article

References (53)

1. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-E136. (Pubitemid 34521026)
2. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003) Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 253:269-285.
3. Hennigan RF, Stambrook PJ (2001) Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes. Mol Biol Cell 12:2352-2363. (Pubitemid 33051961)
4. Young MR, et al. (1999) Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci USA 96:9827-9832. (Pubitemid 29398817)
5. Eferl R, et al. (2003) Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112:181-192. (Pubitemid 36144108)
6. Dong Z, et al. (1997) A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol Carcinog 19:204-212. (Pubitemid 27360138)
7. Lamb RF, et al. (1997) AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol Cell Biol 17:963-976. (Pubitemid 27044395)
8. Cooper SJ, et al. (2003) Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol Cancer Res 1:848-854. (Pubitemid 37174456)
9. Lopez-Bergami P, et al. (2007) Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell 11:447-460. (Pubitemid 46670078)
10. Spangler B, Vardimon L, Bosserhoff AK, Kuphal S (2011) Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma. Pigment Cell Melanoma Res 24:148-164.
11. Mathas S, et al. (2002) Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J 21:4104-4113. (Pubitemid 34857442)
12. Shaulian E, Karin M (2001) AP-1 in cell proliferation and survival. Oncogene 20:2390-2400. (Pubitemid 32531297)
13. van Dam H, et al. (1995) ATF-2 is preferentially activated by stress-activated protein kinases tomediate c-jun inductionin response to genotoxicagents. EMBOJ 14:1798-1811.
14. Karin M (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483-16486.
15. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ (1997) Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296-299. (Pubitemid 27142517)
16. Musti AM, Treier M, Bohmann D (1997) Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science 275:400-402. (Pubitemid 27051620)
17. Lallemand D, et al. (1998) Stress-activated protein kinases are negatively regulated by cell density. EMBO J 17:5615-5626. (Pubitemid 28445973)
18. Knirsh R, et al. (2009) Loss of E-cadherin-mediated cell-cell contacts activates a novel mechanism for up-regulation of the proto-oncogene c-Jun. Mol Biol Cell 20:2121-2129.
19. Reisfeld S, Vardimon L (1994) Cell to cell contacts control the transcription activity of the glucocorticoid receptor. Mol Endocrinol 8:1224-1233. (Pubitemid 24292599)
20. Vardimon L, Ben-Dror I, Oren A, Polak P (2006) Cytoskeletal and cell contact control of the glucocorticoid pathway. Mol Cell Endocrinol 252:142-147.
21. Rüegg J, Holsboer F, Turck C, Rein T (2004) Cofilin 1 is revealed as an inhibitor of glucocorticoid receptor by analysis of hormone-resistant cells. Mol Cell Biol 24:9371-9382. (Pubitemid 39391675)
22. Polak P, et al. (2006) The cytoskeletal network controls c-Jun translation in a UTR-dependent manner. Oncogene 25:665-676. (Pubitemid 43214693)
23. Oren A, et al. (1999) The cytoskeletal network controls c-Jun expression and glucocorticoid receptor transcriptional activity in an antagonistic and cell-type-specific manner. Mol Cell Biol 19:1742-1750. (Pubitemid 29098232)
24. Furnari FB, et al. (2007) Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 21:2683-2710. (Pubitemid 350070717)
25. Rickman DS, et al. (2001) Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 61:6885-6891. (Pubitemid 32896514)
26. Phillips HS, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157-173. (Pubitemid 43357943)
27. van den Boom J, et al. (2003) Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 163:1033-1043.
28. Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM (1988) Induction of protooncogene JUN/AP-1 by serum and TPA. Nature 334:629-631.
29. Treier M, Staszewski LM, Bohmann D (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78:787-798. (Pubitemid 24294454)
30. Sonenberg N, Hinnebusch AG (2009) Regulation of translation initiation in eukaryotes: Mechanisms and biological targets. Cell 136:731-745.
31. Gingras AC, Raught B, Sonenberg N (2001) Regulation of translation initiation by FRAP/mTOR. Genes Dev 15:807-826. (Pubitemid 32295062)
32. Bert AG, Grépin R, Vadas MA, Goodall GJ (2006) Assessing IRES activity in the HIF-1alpha and other cellular 5′ UTRs. RNA 12:1074-1083. (Pubitemid 43788125)
33. Kullmann M, Göpfert U, Siewe B, Hengst L (2002) ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR. Genes Dev 16:3087-3099. (Pubitemid 35424195)
34. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415.
35. Honda M, Beard MR, Ping LH, Lemon SM (1999) A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol 73:1165-1174. (Pubitemid 29036768)
36. Eferl R, Wagner EF (2003) AP-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 3:859-868. (Pubitemid 37383716)
37. van Dam H, et al. (1998) Autocrine growth and anchorage independence: Two complementing Jun-controlled genetic programs of cellular transformation. Genes Dev 12:1227-1239.
38. van Dam H, Castellazzi M (2001) Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis. Oncogene 20:2453-2464.
39. Huang PH, Xu AM, White FM (2009) Oncogenic EGFR signaling networks in glioma. Sci Signal 2(87):re6.
40. Sehgal A, Briggs J, Rinehart-Kim J, Basso J, Bos TJ (2000) The chicken c-Jun 5′ untranslated region directs translation by internal initiation. Oncogene 19:2836-2845. (Pubitemid 30386420)
41. Staber PB, et al. (2007) The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. Blood 110:3374-3383. (Pubitemid 350106332)
42. Short JD, Pfarr CM (2002) Translational regulation of the JunD messenger RNA. J Biol Chem 277:32697-32705. (Pubitemid 34984776)
43. Spahn CM, et al. (2001) Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science 291:1959-1962. (Pubitemid 32216995)
44. Stoneley M, Willis AE (2004) Cellular internal ribosome entry segments: Structures, trans-acting factors and regulation of gene expression. Oncogene 23:3200-3207. (Pubitemid 38638831)
45. Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E (2009) MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 125:1407-1413.
46. Yan B, Chour HH, Peh BK, Lim C, Salto-Tellez M (2006) RhoA protein expression correlates positively with degree of malignancy in astrocytomas. Neurosci Lett 407:124-126. (Pubitemid 44397232)
47. Panopoulos A, Howell M, Fotedar R, Margolis RL (2011) Glioblastoma motility occurs in the absence of actin polymer. Mol Biol Cell 22:2212-2220.
48. Spangler B, et al. (2012) ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int J Cancer 130:2801-2811.
49. Marinissen MJ, et al. (2004) The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol Cell 14:29-41. (Pubitemid 38469907)
50. Kim S, Coulombe PA (2010) Emerging role for the cytoskeleton as an organizer and regulator of translation. Nat Rev Mol Cell Biol 11:75-81.
51. Mor E, et al. (2011) Species-specific microRNA roles elucidated following astrocyte activation. Nucleic Acids Res 39:3710-3723.
52. Rothhammer T, et al. (2004) The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci 61:118-128. (Pubitemid 38121905)
53. Albini A, et al. (1987) A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47:3239-3245. (Pubitemid 17082655)